Table 3 Subgroup analysis of prostate cancer detection rate according to DRE and imaging findings in the different ranges of PSA levels
PSA (ng/ml) | Prostate cancer detection rate (%) (no./total no.) | |||
|---|---|---|---|---|
Negative DRE | Positive DRE | Negative imaging | Positive imaging | |
0–4 | 29.7 (19/64) | 33.3 (2/6) | 27.5 (11/40) | 66.7 (20/30) |
4–10 | 13.5 (29/215) | 58.2 (32/55) | 11.2 (21/187) | 48.2 (40/83) |
10–20 | 25.6 (61/238) | 59.6 (62/104) | 25.7 (54/210) | 52.3 (69/132) |
20–100 | 55.6 (70/126) | 62.8 (76/121) | 54.4 (43/79) | 61.3 (103/168) |
≥ 100 | 0 (0/3) | 96.7 (87/90) | 0 (0/0) | 100.0 (93/93) |
Overall | 27.7 (179/646) | 68.9 (259/376) | 25.0 (129/516) | 64.2 (325/506) |